1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma
(
- Contribution to journal › Letter
-
Mark
Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact
(
- Contribution to journal › Article
-
Mark
Matrix-assisted laser desorption ionization - mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non-small-cell lung cancer mouse xenograft model
(
- Contribution to journal › Letter
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
- 2020
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
(
- Contribution to journal › Article
-
Mark
Dna polymerase alpha subunit b is a binding protein for erlotinib resistance in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Profiling the Protein Targets of Unmodified Bio-Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry
(
- Contribution to journal › Scientific review
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review